The Texas Heart Institute
N

Percutaneous Device Options for the Management of Heart Failure – Present and Future Perspectives

By The Texas Heart Institute FEATURING Nikolaos Diakos
By The Texas Heart Institute FEATURING Nikolaos Diakos
0 views
March 14, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Recommended

AUTOPLAY
08:30
CVRx | Barostim

Real-World Experience with Baroreflex Activation Therapy: On-the-Job…

Feat. P. Mccann
07:22
CVRx | Barostim

Barostim in HFrEF Patients: International Strategies for Patient Sel…

Feat. J. Bauersachs, P. Wenzel, S. Anker, W. Abraham, P. Mccann
12:12
CVRx | Barostim

Challenges and Opportunities with Contemporary GDMT in NYHA Class II…

Feat. W. Abraham
11:37
ACC 2022 Conference Coverage

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

Feat. P. Heidenreich
11:25
ACC 2023 Conference Coverage

ACC 2023: SGLT2i Use - Dos and Don'ts

Feat. A. Armbruster
61:49
Obafemi Awolowo University

Management of Heart Failure

Feat. O. A. Akinyele
27:14
MUSC Cardiology

Which Diuretic(s) Are Best in HF? Update Based on Recent Clinical Tr…

Feat. R. Mentz
09:52
AHA 2022 Conference Coverage

AHA 2022: Torsemide Comparison With Furosemide for Management of Hea…

Feat. R. Mentz
13:07
Michelle Kittleson

2021 ADA Highlights: Heart Failure With Reduced Ejection Fraction - …

12:18
CCM® Therapy

HRS 2024: Cardiac Contractility Modulation - Don’t Wait!

Feat. R. Kahwash
12:08
CCM® Therapy

HRS 2024: Why Cardiac Contractility Modulation?

Feat. J. Singh
31:50
The 10th Annual Western New England Acute Cardiology Conference

Cardiac Surgery Case: Post Cardiotomy Shock Requiring Mechanical Cir…

Feat. K. Wanamaker
12:44
CCM® Therapy

HRS 2024: The Impact of CCM® on My Practice

Feat. S. Jamal
18:26
CVRx | Barostim

HFA 2023: Unlocking the Potential of Baroreflex Activation in Heart …

Feat. F. Zannad, J. Lindenfeld, M. Fudim
16:18
CVRx | Barostim

ISHLT 2024: Integrating Barostim into a Comprehensive Heart Failure …

Feat. D. Yaranov
35:16
Scripps Health

HFpEF or Amyloidosis? The Right Therapies for Right Patients

Feat. M. Kittleson
02:41
CCM® Therapy

CCM® Overview - Provider Education

02:23
CCM® Therapy

CCM® Overview - Patient Education

12:30
Houston Methodist Hospital

Amyloidosis Types and Pathophysiology

Feat. B. Trachtenberg
09:58
CVRx | Barostim

Barostim for HFrEF Patients

Feat. P. Mccann